Stonebridge Financial Group LLC Purchases New Position in Solventum Co. (NYSE:SOLV)

Stonebridge Financial Group LLC acquired a new stake in Solventum Co. (NYSE:SOLV) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 395 shares of the company’s stock, valued at approximately $26,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Modus Advisors LLC bought a new stake in shares of Solventum during the 4th quarter valued at $25,000. Copeland Capital Management LLC bought a new stake in shares of Solventum during the third quarter valued at about $26,000. Crews Bank & Trust purchased a new stake in shares of Solventum in the fourth quarter worth about $32,000. True Wealth Design LLC boosted its position in shares of Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock valued at $33,000 after acquiring an additional 471 shares during the period. Finally, Prospera Private Wealth LLC purchased a new position in Solventum during the third quarter valued at approximately $35,000.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Mizuho assumed coverage on shares of Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target for the company. Piper Sandler boosted their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Finally, Morgan Stanley raised their price target on Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $68.29.

Solventum Price Performance

Shares of NYSE SOLV opened at $74.04 on Friday. The stock’s 50-day moving average is $70.67 and its 200 day moving average is $68.40. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.